Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

158.24 -1.89 (-1.18%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts 
Via Benzinga
Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now
These players could deliver top returns over the long haul. 
Via The Motley Fool
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth
Dow stocks can provide the confidence needed to hold through periods of volatility. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
2 Warren Buffett Dividend Stocks to Buy and Hold Forever
Most people have come across these companies' services. 
Via The Motley Fool
These 2 Dow Stocks Moved Markets This Week
Bulls and bears alike looked closely at these two companies. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Check Out What Whales Are Doing With JNJ
Via Benzinga
Intuitive Surgical's Revenue Dipped: Is It Time to Sell?
A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest. 
Via The Motley Fool
Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review
The major indexes saw significant loses as Treasury yields soared. 
Via Investor's Business Daily
3 Mutual Funds to Invest in for Pro Management and Low Fees
People wanting to invest for the future without actively managing their own money should consider one of these top mutual funds. 
Via InvestorPlace
The 7 Best Forever Stocks To Buy Now: October 2023
These best forever stocks have consistently grown their cash flows even in uncertain times and are category leaders set for dominance. 
Via InvestorPlace
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023
From Johnson & Johnson
Via Business Wire
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous. 
Via The Motley Fool
7 Dividend Aristocrats That Are Built to Last
For dependability and durability, take a closer look at these seven dividend stocks, all of which hold aristocratic status. 
Via InvestorPlace
Why Johnson & Johnson Stock Flopped Today
Perhaps those third-quarter results weren't as impressive as they first appeared to be. 
Via The Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
Legend Biotech Corporation's (NASDAQ: LEGN) partner, Johnson & Johnson (NYSE: JNJ), reported Q3 Carvykti revenues of $152 million,  
Via Benzinga
1 Warren Buffett Stock to Buy Hand Over Fist Right Now
This blue-chip healthcare stock is a solid pick for investors in uncertain times. 
Via The Motley Fool
Oversold and Overextended, Abbott Laboratories is a Great Buy
Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying. 
Via MarketBeat
Exposures COVID-19
Dividend Income Update September 2023
With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income. 
Via Talk Markets
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
Some things are different about J&J. But other things remain the same as they've been for a long time. 
Via The Motley Fool
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
The healthcare behemoth reported strong earnings after separating its consumer health division. 
Via The Motley Fool
Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher
(Tuesday market open) Early earnings results continued to impress but major indexes flagged in premarket trading Tuesday as Treasury yields swung higher after unexpectedly strong September U.S. Retail... 
Via Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
Healthcare company Johnson & Johnson (J&J) (NYSE: JNJ) shared its financial outcomes for the third quarter of 2023, reflecting:  
Via Benzinga
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine
Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical... 
Via Benzinga
Iran Warning Stops The Market Rally Buy Historic Biden Visit To Israel Is A Positive For The Market
To gain an edge, this is what you need to know today. 
Via Benzinga
Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard
Earnings season is starting to ramp up. 
Via The Motley Fool
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff. 
Via Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse 
Via Benzinga
Topics Earnings
Exposures Financial
US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.